CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Protobios focuses on early diagnosis of chronic diseases by utilizing a high-throughput technology called Mimotope Variation Analysis (MVA) to discover new biomarkers. This technology enables simultaneous detection of multiple disease signatures, enhancing diagnostic accuracy and supporting therapeutic development.
Chronic diseases (cancer, heart and mind diseases) are the leading causes of illness and death.
By 2020 their contribution is expected to rise to 73% of all deaths (of which nearly half as premature).
To radically reduce the related healthcare spending and contribute to healthy ageing, it is important to diagnose these diseases as early and accurately as possible by analyzing biomarkers.
However, the current analytical platforms have been unable to handle the huge amounts of data that need to be…
PROTOBIOS OU
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
